Prosensa slips, drisapersen paper in focus

|About: Prosensa Holding N.V. (RNA)|By:, SA News Editor

Shares of Prosensa (RNA -1.9%) are weaker on the session.

Chatter indicates the move might be attributable to a new paper discussing the pharmacokinetics and safety of drisapersen in non-ambulant DMD patients. (full article)

Shares of Sarepta Therapeutics (SRPT) spiked early before quickly retracing gains.